Use of shp2 inhibitors for inhibiting senescence
US-2025134885-A1 · May 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Valet Philippe patents
Valet Philippe is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Valet Philippe |
| Total patents | 16 |
| First publication | Oct 15, 2015 |
| Latest publication | May 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of shp2 inhibitors for the treatment of insulin resistance
US-2025090529-A1 · Mar 20, 2025 · US
Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
US-2024226238-A1 · Jul 11, 2024 · US
Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
US-11896649-B2 · Feb 13, 2024 · US
Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
US-2023093887-A1 · Mar 30, 2023 · US
Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
US-11484577-B2 · Nov 1, 2022 · US
Use of shp2 inhibitors for the treatment of insulin resistance
US-2022000869-A1 · Jan 6, 2022 · US
Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction
US-2021196798-A1 · Jul 1, 2021 · US
Method and pharmaceutical composition for use in the treatment of diabetes
US-2020171127-A1 · Jun 4, 2020 · US
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
US-2020081009-A1 · Mar 12, 2020 · US
Recent patents
Latest publications not already listed above.
Method and pharmaceutical composition for use in the treatment of diabetes
US-10426818-B2 · Oct 1, 2019 · US
Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
US-10401365-B2 · Sep 3, 2019 · US
Method and pharmaceutical composition for use in the treatment of diabetes
US-2018104306-A1 · Apr 19, 2018 · US
Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
US-2017131282-A1 · May 11, 2017 · US
Pharmaceutical composition for use in the treatment of dysfunction associated with aging
US-9381229-B2 · Jul 5, 2016 · US
Pharmaceutical composition for use in the treatment of dysfunction associated with aging
US-2015290286-A1 · Oct 15, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Toulouse 3 Paul Sabatier | 14 |
| Ct Hospitalier Universitaire Toulouse | 12 |
| Inst Nat Sante Rech Med | 11 |
| Centre Nat Rech Scient | 4 |
| Inserm Insitut National De La Sante Et De La Rech Medicale | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K38/1709 | 10 |
| A61P43/00 | 8 |
| A61P3/10 | 6 |
| A61K31/08 | 5 |
| A61K33/00 | 5 |